-
Aurora Cannabis (ACB) Announces $125 Million Bought Deal Financing
-
Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing
-
UPDATE: Aurora Cannabis (ACB:CN) (ACB) PT Lowered to Cdn$4 at BMO Capital
-
Aurora Cannabis (ACB) Announces Filing of Prospectus Supplement for At-The-Market Offering Program
-
Aurora Announces Filing of Prospectus Supplement for At-The-Market Offering Program
-
Aurora to Participate in BMO Capital Markets Farm to Market Virtual Conference
-
UPDATE: BMO Capital Upgrades Aurora Cannabis Inc. (ACB:CN) (ACB) to Market Perform
-
Aurora Cannabis Announces Fiscal 2021 Second Quarter Results
-
Aurora Cannabis Closes Previously Announced Bought Deal Financing Over-Allotment Option Exercised in Full
-
Aurora Cannabis Closes Previously Announced Bought Deal Financing
-
Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing
-
Aurora Cannabis (ACB) Announces $125 Million Bought Deal Financing of Common Stock, Warrants
-
Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing
-
BMO Capital Downgrades Aurora Cannabis (ACB:CN) (ACB) to Underperform
-
Aurora Cannabis Closes Previously Announced Upsized Underwritten Public Offering Over-Allotment Option Exercised in Full
-
Aurora Cannabis Closes Previously Announced Upsized Underwritten Public Offering
-
Aurora Cannabis (ACB) Prices $150 Million Underwritten Public Offering of Common Shares, Warrants
-
Aurora Cannabis Prices US$150 Million Underwritten Public Offering
-
Aurora Cannabis (ACB) Announces $125M Proposed Public Offering
-
Aurora Cannabis Announces Proposed Public Offering
-
Aurora Cannabis (ACB) Reports Mixed Results BMO Cuts PT to $10 from $24
-
Aurora Cannabis (ACB:CN) (ACB) PT Lowered to Cdn$3 at BMO Capital
-
Aurora Cannabis Announces Financial Results for the Third Quarter of Fiscal 2019
-
Aurora Cannabis Expands Management Team to Support Strategic Initiatives
-
Aurora Cannabis to Acquire MedReleaf
-
Canada's small financial firms get buzz from weed stocks

